Santen Pharmaceutical Co., Ltd.
SNPHY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $64 | $85 | $93 | $78 |
| Short-Term Investments | $3 | $0 | $1 | $0 |
| Receivables | $63 | $67 | $72 | $69 |
| Inventory | $59 | $59 | $52 | $50 |
| Other Curr. Assets | $7 | $10 | $7 | $8 |
| Total Curr. Assets | $195 | $221 | $224 | $205 |
| Property Plant & Equip (Net) | $75 | $73 | $73 | $74 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $78 | $74 | $75 | $80 |
| Long-Term Investments | $0 | $0 | $27 | $29 |
| Tax Assets | $11 | $0 | $10 | $0 |
| Other NC Assets | $31 | $40 | $0 | $10 |
| Total NC Assets | $194 | $187 | $185 | $193 |
| Other Assets | $0 | $0 | -$0 | $0 |
| Total Assets | $389 | $408 | $409 | $398 |
| Liabilities | – | – | – | – |
| Payables | $31 | $42 | $39 | $36 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $3 | $0 | $2 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $40 | $44 | $42 | $43 |
| Total Curr. Liab. | $74 | $86 | $87 | $79 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $3 | $0 | $3 | $0 |
| Other NC Liab. | $39 | $41 | $35 | $37 |
| Total NC Liab. | $42 | $41 | $37 | $37 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $7 | $0 |
| Total Liabilities | $116 | $128 | $124 | $115 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $9 | $9 | $9 | $9 |
| Retained Earnings | $236 | $228 | $228 | $227 |
| AOCI | $0 | $44 | $41 | $48 |
| Other Equity | $49 | $0 | $0 | $0 |
| Total Equity | $275 | $281 | $286 | $284 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$1 | -$1 | -$1 | -$1 |
| Total Liab. & Tot. Equity | $389 | $408 | $409 | $398 |
| Net Debt | -$64 | -$85 | -$93 | -$78 |